This study is testing a drug called Talazoparib for patients with a specific type of breast cancer. Breast cancer is a disease where cells in the breast grow out of control. Some people have a change in their DNA, called a BRCA mutation, which can cause cancer to spread to other parts of the body, called metastatic cancer. Talazoparib is a medication being studied to see if it can stop cancer cells from growing by blocking proteins called PARPs that help repair damaged DNA.
- This study lasts several months and involves regular doctor visits.
- Participants must have specific cancer mutations and cannot have used a similar drug before.
- Patients are not paid but may receive free medication and health check-ups.
Before joining, make sure to discuss with your doctor, as there are specific health requirements and risks involved. Also, patients need to be at least 18 years old and cannot be pregnant or breastfeeding during the study.
How understandable was the trial content above?
Hard to understand
Easy to understand